nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—SLC22A6—Pravastatin—atherosclerosis	0.327	1	CbGbCtD
Gentamicin—LRP2—Retinoid metabolism and transport—APOA4—atherosclerosis	0.0173	0.044	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOA2—atherosclerosis	0.0149	0.0379	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOC3—atherosclerosis	0.0112	0.0285	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—LDLR—atherosclerosis	0.0111	0.0284	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—MPO—atherosclerosis	0.0094	0.024	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—LDLR—atherosclerosis	0.00934	0.0238	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—F7—atherosclerosis	0.00902	0.023	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOA4—atherosclerosis	0.00881	0.0225	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SCARB1—atherosclerosis	0.00874	0.0223	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—PLAT—atherosclerosis	0.00804	0.0205	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOA2—atherosclerosis	0.00759	0.0193	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ABCA1—atherosclerosis	0.00736	0.0187	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOB—atherosclerosis	0.0072	0.0183	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—LPL—atherosclerosis	0.00687	0.0175	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—PLG—atherosclerosis	0.00684	0.0174	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD1—atherosclerosis	0.00656	0.0167	CbGpPWpGaD
Gentamicin—Laryngeal oedema—Niacin—atherosclerosis	0.00642	0.0229	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOB—atherosclerosis	0.00604	0.0154	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—atherosclerosis	0.0059	0.015	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—CCL5—atherosclerosis	0.0059	0.015	CbGpPWpGaD
Gentamicin—Hepatomegaly—Niacin—atherosclerosis	0.00582	0.0207	CcSEcCtD
Gentamicin—LRP2—Retinoid metabolism and transport—APOE—atherosclerosis	0.00576	0.0147	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOC3—atherosclerosis	0.00571	0.0146	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOA1—atherosclerosis	0.00569	0.0145	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—LDLR—atherosclerosis	0.00568	0.0145	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—MTHFR—atherosclerosis	0.0052	0.0132	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—CRP—atherosclerosis	0.00494	0.0126	CbGpPWpGaD
Gentamicin—Numbness—Pravastatin—atherosclerosis	0.00489	0.0174	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOE—atherosclerosis	0.00484	0.0123	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOA1—atherosclerosis	0.00478	0.0122	CbGpPWpGaD
Gentamicin—Sensory loss—Pravastatin—atherosclerosis	0.00468	0.0167	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—F2—atherosclerosis	0.00456	0.0116	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ICAM1—atherosclerosis	0.00454	0.0116	CbGpPWpGaD
Gentamicin—Hearing impaired—Pravastatin—atherosclerosis	0.00426	0.0152	CcSEcCtD
Gentamicin—Muscle twitching—Niacin—atherosclerosis	0.0042	0.0149	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—INS—atherosclerosis	0.00413	0.0105	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—CCL2—atherosclerosis	0.00407	0.0104	CbGpPWpGaD
Gentamicin—Vascular purpura—Lovastatin—atherosclerosis	0.00389	0.0139	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—SERPINE1—atherosclerosis	0.0038	0.00968	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—atherosclerosis	0.00379	0.00966	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOB—atherosclerosis	0.00367	0.00937	CbGpPWpGaD
Gentamicin—Vascular purpura—Simvastatin—atherosclerosis	0.00364	0.013	CcSEcCtD
Gentamicin—Muscular weakness—Rosuvastatin—atherosclerosis	0.00362	0.0129	CcSEcCtD
Gentamicin—Purpura—Lovastatin—atherosclerosis	0.00361	0.0129	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00354	0.00902	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—LPL—atherosclerosis	0.00351	0.00894	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IFNG—atherosclerosis	0.00346	0.00881	CbGpPWpGaD
Gentamicin—Purpura—Simvastatin—atherosclerosis	0.00338	0.012	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00333	0.00848	CbGpPWpGaD
Gentamicin—Deafness—Pravastatin—atherosclerosis	0.00329	0.0117	CcSEcCtD
Gentamicin—Vascular purpura—Pravastatin—atherosclerosis	0.00329	0.0117	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—atherosclerosis	0.00315	0.00803	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0031	0.0111	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.00308	0.00786	CbGpPWpGaD
Gentamicin—Purpura—Pravastatin—atherosclerosis	0.00306	0.0109	CcSEcCtD
Gentamicin—Muscular weakness—Ezetimibe—atherosclerosis	0.00301	0.0107	CcSEcCtD
Gentamicin—Eosinophilia—Lovastatin—atherosclerosis	0.00298	0.0106	CcSEcCtD
Gentamicin—LRP2—Diseases associated with visual transduction—APOE—atherosclerosis	0.00294	0.0075	CbGpPWpGaD
Gentamicin—Eosinophilia—Ezetimibe—atherosclerosis	0.00292	0.0104	CcSEcCtD
Gentamicin—LRP2—Diseases associated with visual transduction—APOA1—atherosclerosis	0.00291	0.00741	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00289	0.00736	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00289	0.00736	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.00288	0.00733	CbGpPWpGaD
Gentamicin—Muscular weakness—Simvastatin—atherosclerosis	0.00287	0.0102	CcSEcCtD
Gentamicin—Eosinophilia—Simvastatin—atherosclerosis	0.00279	0.00993	CcSEcCtD
Gentamicin—Muscular weakness—Niacin—atherosclerosis	0.00264	0.00939	CcSEcCtD
Gentamicin—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00263	0.00937	CcSEcCtD
Gentamicin—Muscular weakness—Pravastatin—atherosclerosis	0.0026	0.00925	CcSEcCtD
Gentamicin—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00258	0.00919	CcSEcCtD
Gentamicin—Eosinophilia—Pravastatin—atherosclerosis	0.00252	0.00897	CcSEcCtD
Gentamicin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00246	0.00876	CcSEcCtD
Gentamicin—Weight decreased—Pravastatin—atherosclerosis	0.0023	0.0082	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00228	0.00581	CbGpPWpGaD
Gentamicin—Stomatitis—Niacin—atherosclerosis	0.00225	0.008	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—atherosclerosis	0.00224	0.0057	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00223	0.00792	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00214	0.00547	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00214	0.00547	CbGpPWpGaD
Gentamicin—Alopecia—Lovastatin—atherosclerosis	0.00213	0.00758	CcSEcCtD
Gentamicin—Arthralgia—Rosuvastatin—atherosclerosis	0.00211	0.0075	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00211	0.00537	CbGpPWpGaD
Gentamicin—Alopecia—Ezetimibe—atherosclerosis	0.00209	0.00744	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00207	0.00527	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Niacin—atherosclerosis	0.00206	0.00733	CcSEcCtD
Gentamicin—Erythema—Ezetimibe—atherosclerosis	0.00206	0.00732	CcSEcCtD
Gentamicin—Confusional state—Rosuvastatin—atherosclerosis	0.00204	0.00725	CcSEcCtD
Gentamicin—Hypoaesthesia—Pravastatin—atherosclerosis	0.00203	0.00722	CcSEcCtD
Gentamicin—Visual impairment—Niacin—atherosclerosis	0.00199	0.0071	CcSEcCtD
Gentamicin—Alopecia—Simvastatin—atherosclerosis	0.00199	0.00709	CcSEcCtD
Gentamicin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00198	0.00704	CcSEcCtD
Gentamicin—Visual impairment—Pravastatin—atherosclerosis	0.00196	0.00699	CcSEcCtD
Gentamicin—Erythema—Simvastatin—atherosclerosis	0.00196	0.00698	CcSEcCtD
Gentamicin—Tinnitus—Niacin—atherosclerosis	0.00193	0.00687	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00191	0.00487	CbGpPWpGaD
Gentamicin—Anaemia—Ezetimibe—atherosclerosis	0.0019	0.00677	CcSEcCtD
Gentamicin—Tinnitus—Pravastatin—atherosclerosis	0.0019	0.00676	CcSEcCtD
Gentamicin—Vertigo—Lovastatin—atherosclerosis	0.00188	0.00671	CcSEcCtD
Gentamicin—Leukopenia—Lovastatin—atherosclerosis	0.00188	0.00668	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00184	0.00655	CcSEcCtD
Gentamicin—Alopecia—Niacin—atherosclerosis	0.00183	0.00651	CcSEcCtD
Gentamicin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00181	0.00646	CcSEcCtD
Gentamicin—Anaemia—Simvastatin—atherosclerosis	0.00181	0.00646	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00181	0.00462	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00181	0.00462	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00181	0.00462	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00181	0.00462	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—atherosclerosis	0.00181	0.0046	CbGpPWpGaD
Gentamicin—Erythema—Niacin—atherosclerosis	0.0018	0.00641	CcSEcCtD
Gentamicin—Alopecia—Pravastatin—atherosclerosis	0.0018	0.00641	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00179	0.00456	CbGpPWpGaD
Gentamicin—Arthralgia—Lovastatin—atherosclerosis	0.00179	0.00636	CcSEcCtD
Gentamicin—Hypertension—Ezetimibe—atherosclerosis	0.00178	0.00632	CcSEcCtD
Gentamicin—Vertigo—Simvastatin—atherosclerosis	0.00176	0.00628	CcSEcCtD
Gentamicin—Leukopenia—Simvastatin—atherosclerosis	0.00176	0.00625	CcSEcCtD
Gentamicin—Arthralgia—Ezetimibe—atherosclerosis	0.00175	0.00624	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00173	0.00441	CbGpPWpGaD
Gentamicin—Confusional state—Lovastatin—atherosclerosis	0.00173	0.00615	CcSEcCtD
Gentamicin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00171	0.00609	CcSEcCtD
Gentamicin—Confusional state—Ezetimibe—atherosclerosis	0.00169	0.00603	CcSEcCtD
Gentamicin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00168	0.00598	CcSEcCtD
Gentamicin—Thrombocytopenia—Lovastatin—atherosclerosis	0.00168	0.00597	CcSEcCtD
Gentamicin—Arthralgia—Simvastatin—atherosclerosis	0.00167	0.00595	CcSEcCtD
Gentamicin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00166	0.00593	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00166	0.00422	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00164	0.00585	CcSEcCtD
Gentamicin—Anaemia—Pravastatin—atherosclerosis	0.00164	0.00584	CcSEcCtD
Gentamicin—Vertigo—Niacin—atherosclerosis	0.00162	0.00576	CcSEcCtD
Gentamicin—Confusional state—Simvastatin—atherosclerosis	0.00161	0.00575	CcSEcCtD
Gentamicin—Leukopenia—Niacin—atherosclerosis	0.00161	0.00574	CcSEcCtD
Gentamicin—Urticaria—Rosuvastatin—atherosclerosis	0.0016	0.00571	CcSEcCtD
Gentamicin—Anaphylactic shock—Simvastatin—atherosclerosis	0.0016	0.0057	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.0016	0.00407	CbGpPWpGaD
Gentamicin—Vertigo—Pravastatin—atherosclerosis	0.00159	0.00567	CcSEcCtD
Gentamicin—Leukopenia—Pravastatin—atherosclerosis	0.00159	0.00565	CcSEcCtD
Gentamicin—LRP2—Metabolism—LDLRAP1—atherosclerosis	0.00158	0.00402	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00157	0.00558	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00156	0.00555	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00154	0.00393	CbGpPWpGaD
Gentamicin—Paraesthesia—Lovastatin—atherosclerosis	0.00154	0.00547	CcSEcCtD
Gentamicin—Arthralgia—Niacin—atherosclerosis	0.00153	0.00546	CcSEcCtD
Gentamicin—Hypertension—Pravastatin—atherosclerosis	0.00153	0.00545	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00153	0.00545	CcSEcCtD
Gentamicin—Arthralgia—Pravastatin—atherosclerosis	0.00151	0.00538	CcSEcCtD
Gentamicin—Paraesthesia—Ezetimibe—atherosclerosis	0.00151	0.00537	CcSEcCtD
Gentamicin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00149	0.0053	CcSEcCtD
Gentamicin—Decreased appetite—Lovastatin—atherosclerosis	0.00149	0.0053	CcSEcCtD
Gentamicin—LRP2—Metabolism—PLTP—atherosclerosis	0.00148	0.00378	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Niacin—atherosclerosis	0.00147	0.00523	CcSEcCtD
Gentamicin—Confusional state—Pravastatin—atherosclerosis	0.00146	0.0052	CcSEcCtD
Gentamicin—Decreased appetite—Ezetimibe—atherosclerosis	0.00146	0.0052	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00146	0.00519	CcSEcCtD
Gentamicin—Anaphylactic shock—Pravastatin—atherosclerosis	0.00145	0.00515	CcSEcCtD
Gentamicin—Paraesthesia—Simvastatin—atherosclerosis	0.00144	0.00512	CcSEcCtD
Gentamicin—Pruritus—Rosuvastatin—atherosclerosis	0.00143	0.00509	CcSEcCtD
Gentamicin—Thrombocytopenia—Pravastatin—atherosclerosis	0.00142	0.00505	CcSEcCtD
Gentamicin—Feeling abnormal—Lovastatin—atherosclerosis	0.00141	0.00502	CcSEcCtD
Gentamicin—Decreased appetite—Simvastatin—atherosclerosis	0.00139	0.00496	CcSEcCtD
Gentamicin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00138	0.00493	CcSEcCtD
Gentamicin—Hypotension—Niacin—atherosclerosis	0.00137	0.00489	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00137	0.0035	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00136	0.00348	CbGpPWpGaD
Gentamicin—Urticaria—Lovastatin—atherosclerosis	0.00136	0.00484	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00136	0.00346	CbGpPWpGaD
Gentamicin—Body temperature increased—Lovastatin—atherosclerosis	0.00135	0.00482	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00134	0.00477	CcSEcCtD
Gentamicin—Dizziness—Rosuvastatin—atherosclerosis	0.00134	0.00476	CcSEcCtD
Gentamicin—Urticaria—Ezetimibe—atherosclerosis	0.00133	0.00475	CcSEcCtD
Gentamicin—Body temperature increased—Ezetimibe—atherosclerosis	0.00133	0.00473	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00132	0.00338	CbGpPWpGaD
Gentamicin—Paraesthesia—Niacin—atherosclerosis	0.00132	0.0047	CcSEcCtD
Gentamicin—Feeling abnormal—Simvastatin—atherosclerosis	0.00132	0.0047	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00132	0.0047	CcSEcCtD
Gentamicin—Paraesthesia—Pravastatin—atherosclerosis	0.0013	0.00463	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCG8—atherosclerosis	0.00129	0.00328	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LTA4H—atherosclerosis	0.00129	0.00328	CbGpPWpGaD
Gentamicin—Decreased appetite—Niacin—atherosclerosis	0.00128	0.00455	CcSEcCtD
Gentamicin—Rash—Rosuvastatin—atherosclerosis	0.00127	0.00453	CcSEcCtD
Gentamicin—Dermatitis—Rosuvastatin—atherosclerosis	0.00127	0.00453	CcSEcCtD
Gentamicin—Urticaria—Simvastatin—atherosclerosis	0.00127	0.00453	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00127	0.00323	CbGpPWpGaD
Gentamicin—Body temperature increased—Simvastatin—atherosclerosis	0.00127	0.00451	CcSEcCtD
Gentamicin—Headache—Rosuvastatin—atherosclerosis	0.00127	0.00451	CcSEcCtD
Gentamicin—Hypersensitivity—Lovastatin—atherosclerosis	0.00126	0.00449	CcSEcCtD
Gentamicin—Decreased appetite—Pravastatin—atherosclerosis	0.00126	0.00448	CcSEcCtD
Gentamicin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00124	0.0044	CcSEcCtD
Gentamicin—Pruritus—Lovastatin—atherosclerosis	0.00121	0.00431	CcSEcCtD
Gentamicin—Nausea—Rosuvastatin—atherosclerosis	0.0012	0.00427	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.0012	0.00305	CbGpPWpGaD
Gentamicin—Feeling abnormal—Pravastatin—atherosclerosis	0.00119	0.00425	CcSEcCtD
Gentamicin—Pruritus—Ezetimibe—atherosclerosis	0.00119	0.00423	CcSEcCtD
Gentamicin—Hypersensitivity—Simvastatin—atherosclerosis	0.00118	0.0042	CcSEcCtD
Gentamicin—Urticaria—Niacin—atherosclerosis	0.00117	0.00416	CcSEcCtD
Gentamicin—Body temperature increased—Niacin—atherosclerosis	0.00116	0.00414	CcSEcCtD
Gentamicin—Urticaria—Pravastatin—atherosclerosis	0.00115	0.00409	CcSEcCtD
Gentamicin—Body temperature increased—Pravastatin—atherosclerosis	0.00114	0.00407	CcSEcCtD
Gentamicin—Pruritus—Simvastatin—atherosclerosis	0.00113	0.00403	CcSEcCtD
Gentamicin—Dizziness—Lovastatin—atherosclerosis	0.00113	0.00403	CcSEcCtD
Gentamicin—LRP2—Disease—APOA4—atherosclerosis	0.00112	0.00285	CbGpPWpGaD
Gentamicin—Dizziness—Ezetimibe—atherosclerosis	0.00111	0.00395	CcSEcCtD
Gentamicin—Vomiting—Lovastatin—atherosclerosis	0.00109	0.00388	CcSEcCtD
Gentamicin—Hypersensitivity—Niacin—atherosclerosis	0.00108	0.00386	CcSEcCtD
Gentamicin—Rash—Lovastatin—atherosclerosis	0.00108	0.00384	CcSEcCtD
Gentamicin—Dermatitis—Lovastatin—atherosclerosis	0.00108	0.00384	CcSEcCtD
Gentamicin—Headache—Lovastatin—atherosclerosis	0.00107	0.00382	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00107	0.00272	CbGpPWpGaD
Gentamicin—Vomiting—Ezetimibe—atherosclerosis	0.00107	0.0038	CcSEcCtD
Gentamicin—Hypersensitivity—Pravastatin—atherosclerosis	0.00107	0.0038	CcSEcCtD
Gentamicin—Dizziness—Simvastatin—atherosclerosis	0.00106	0.00377	CcSEcCtD
Gentamicin—Rash—Ezetimibe—atherosclerosis	0.00106	0.00377	CcSEcCtD
Gentamicin—Dermatitis—Ezetimibe—atherosclerosis	0.00106	0.00377	CcSEcCtD
Gentamicin—Headache—Ezetimibe—atherosclerosis	0.00105	0.00374	CcSEcCtD
Gentamicin—Pruritus—Niacin—atherosclerosis	0.00104	0.0037	CcSEcCtD
Gentamicin—Pruritus—Pravastatin—atherosclerosis	0.00102	0.00365	CcSEcCtD
Gentamicin—Vomiting—Simvastatin—atherosclerosis	0.00102	0.00362	CcSEcCtD
Gentamicin—Nausea—Lovastatin—atherosclerosis	0.00102	0.00362	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCG1—atherosclerosis	0.00102	0.00259	CbGpPWpGaD
Gentamicin—Rash—Simvastatin—atherosclerosis	0.00101	0.00359	CcSEcCtD
Gentamicin—Dermatitis—Simvastatin—atherosclerosis	0.00101	0.00359	CcSEcCtD
Gentamicin—Headache—Simvastatin—atherosclerosis	0.001	0.00357	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HRH1—atherosclerosis	0.000999	0.00255	CbGpPWpGaD
Gentamicin—Nausea—Ezetimibe—atherosclerosis	0.000997	0.00355	CcSEcCtD
Gentamicin—Dizziness—Niacin—atherosclerosis	0.000972	0.00346	CcSEcCtD
Gentamicin—LRP2—Disease—APOA2—atherosclerosis	0.000964	0.00246	CbGpPWpGaD
Gentamicin—Dizziness—Pravastatin—atherosclerosis	0.000957	0.00341	CcSEcCtD
Gentamicin—LRP2—Metabolism—LCAT—atherosclerosis	0.000955	0.00243	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—FABP4—atherosclerosis	0.000955	0.00243	CbGpPWpGaD
Gentamicin—Nausea—Simvastatin—atherosclerosis	0.000951	0.00339	CcSEcCtD
Gentamicin—LRP2—Metabolism—APOA4—atherosclerosis	0.000937	0.00239	CbGpPWpGaD
Gentamicin—Vomiting—Niacin—atherosclerosis	0.000935	0.00333	CcSEcCtD
Gentamicin—Rash—Niacin—atherosclerosis	0.000927	0.0033	CcSEcCtD
Gentamicin—Dermatitis—Niacin—atherosclerosis	0.000926	0.0033	CcSEcCtD
Gentamicin—Headache—Niacin—atherosclerosis	0.000921	0.00328	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP7A1—atherosclerosis	0.000921	0.00235	CbGpPWpGaD
Gentamicin—Vomiting—Pravastatin—atherosclerosis	0.00092	0.00328	CcSEcCtD
Gentamicin—Rash—Pravastatin—atherosclerosis	0.000913	0.00325	CcSEcCtD
Gentamicin—Dermatitis—Pravastatin—atherosclerosis	0.000912	0.00325	CcSEcCtD
Gentamicin—Headache—Pravastatin—atherosclerosis	0.000907	0.00323	CcSEcCtD
Gentamicin—LRP2—Disease—BGN—atherosclerosis	0.00089	0.00227	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000878	0.00224	CbGpPWpGaD
Gentamicin—Nausea—Niacin—atherosclerosis	0.000873	0.00311	CcSEcCtD
Gentamicin—Nausea—Pravastatin—atherosclerosis	0.00086	0.00306	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP27A1—atherosclerosis	0.000851	0.00217	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000838	0.00214	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000818	0.00208	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALOX5AP—atherosclerosis	0.000807	0.00206	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOA2—atherosclerosis	0.000807	0.00206	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLA2G2A—atherosclerosis	0.000807	0.00206	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALOX15—atherosclerosis	0.000807	0.00206	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCG5—atherosclerosis	0.000797	0.00203	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000796	0.00203	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOA4—atherosclerosis	0.000784	0.002	CbGpPWpGaD
Gentamicin—LRP2—Disease—CST3—atherosclerosis	0.000776	0.00198	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LPA—atherosclerosis	0.00077	0.00196	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—BGN—atherosclerosis	0.000746	0.0019	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00074	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOA5—atherosclerosis	0.000738	0.00188	CbGpPWpGaD
Gentamicin—LRP2—Disease—NAMPT—atherosclerosis	0.000735	0.00187	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOC3—atherosclerosis	0.000726	0.00185	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL4—atherosclerosis	0.000722	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Disease—LDLR—atherosclerosis	0.000721	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000717	0.00183	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLA2G1B—atherosclerosis	0.00071	0.00181	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000702	0.00179	CbGpPWpGaD
Gentamicin—LRP2—Disease—HSPA1B—atherosclerosis	0.000697	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000696	0.00177	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000694	0.00177	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALOX5—atherosclerosis	0.000686	0.00175	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOA2—atherosclerosis	0.000675	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Disease—NCF1—atherosclerosis	0.000675	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—UTS2—atherosclerosis	0.000644	0.00164	CbGpPWpGaD
Gentamicin—LRP2—Disease—CYBA—atherosclerosis	0.000634	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000634	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Disease—PARP1—atherosclerosis	0.000621	0.00158	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CX3CR1—atherosclerosis	0.000617	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASR—atherosclerosis	0.000617	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NAMPT—atherosclerosis	0.000615	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000612	0.00156	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LIPC—atherosclerosis	0.000612	0.00156	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOC3—atherosclerosis	0.000608	0.00155	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CX3CL1—atherosclerosis	0.000605	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LDLR—atherosclerosis	0.000604	0.00154	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000601	0.00153	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CETP—atherosclerosis	0.00059	0.0015	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000576	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CNR2—atherosclerosis	0.000574	0.00146	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SCARB1—atherosclerosis	0.000565	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00055	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HMGCR—atherosclerosis	0.000534	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VWF—atherosclerosis	0.000511	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOC3—atherosclerosis	0.000508	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LDLR—atherosclerosis	0.000505	0.00129	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL3—atherosclerosis	0.000493	0.00126	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000481	0.00123	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCA1—atherosclerosis	0.000476	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCF1—atherosclerosis	0.000472	0.0012	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOB—atherosclerosis	0.000467	0.00119	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000455	0.00116	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCR2—atherosclerosis	0.000446	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDNRA—atherosclerosis	0.000446	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Disease—LPL—atherosclerosis	0.000446	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CYBA—atherosclerosis	0.000444	0.00113	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLAT—atherosclerosis	0.000435	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PARP1—atherosclerosis	0.000435	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GHRL—atherosclerosis	0.000435	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRKCG—atherosclerosis	0.000433	0.0011	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000413	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HMOX1—atherosclerosis	0.000408	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTHFR—atherosclerosis	0.000401	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOB—atherosclerosis	0.000391	0.000996	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFB—atherosclerosis	0.000391	0.000996	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KNG1—atherosclerosis	0.000382	0.000973	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—atherosclerosis	0.00038	0.000969	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGTR1—atherosclerosis	0.000379	0.000967	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOE—atherosclerosis	0.000374	0.000952	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LPL—atherosclerosis	0.000373	0.000951	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000371	0.000946	CbGpPWpGaD
Gentamicin—LRP2—Disease—CAV1—atherosclerosis	0.00037	0.000943	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLG—atherosclerosis	0.00037	0.000942	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOA1—atherosclerosis	0.000369	0.000941	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GPX1—atherosclerosis	0.000364	0.000928	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000357	0.000911	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CD36—atherosclerosis	0.000355	0.000904	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SOCS3—atherosclerosis	0.00035	0.000893	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS2—atherosclerosis	0.000348	0.000887	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP3—atherosclerosis	0.000338	0.000862	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF2—atherosclerosis	0.000337	0.000858	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—atherosclerosis	0.000336	0.000857	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARA—atherosclerosis	0.00033	0.00084	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOB—atherosclerosis	0.000327	0.000833	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDN1—atherosclerosis	0.000322	0.00082	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AGT—atherosclerosis	0.000319	0.000814	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL5—atherosclerosis	0.000319	0.000814	CbGpPWpGaD
Gentamicin—LRP2—Disease—INS—atherosclerosis	0.000319	0.000813	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOE—atherosclerosis	0.000313	0.000797	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPL—atherosclerosis	0.000312	0.000796	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAV1—atherosclerosis	0.00031	0.00079	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOA1—atherosclerosis	0.000309	0.000788	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCG—atherosclerosis	0.000303	0.000773	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPP1—atherosclerosis	0.000296	0.000753	CbGpPWpGaD
Gentamicin—LRP2—Disease—SERPINE1—atherosclerosis	0.000293	0.000747	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—atherosclerosis	0.000282	0.00072	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS3—atherosclerosis	0.00028	0.000713	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFB—atherosclerosis	0.000273	0.000697	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—atherosclerosis	0.000272	0.000695	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—INS—atherosclerosis	0.000267	0.000681	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGT—atherosclerosis	0.000267	0.000681	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000265	0.000674	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LEP—atherosclerosis	0.000262	0.000667	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOE—atherosclerosis	0.000262	0.000667	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CAV1—atherosclerosis	0.000259	0.000661	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOA1—atherosclerosis	0.000259	0.000659	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—atherosclerosis	0.000256	0.000652	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ESR1—atherosclerosis	0.00025	0.000637	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—F2—atherosclerosis	0.000247	0.000629	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—atherosclerosis	0.000245	0.000625	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—atherosclerosis	0.000236	0.000602	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NOS3—atherosclerosis	0.000234	0.000597	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000233	0.000594	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—INS—atherosclerosis	0.000223	0.00057	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL2—atherosclerosis	0.00022	0.00056	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—atherosclerosis	0.000216	0.000551	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000216	0.000551	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—atherosclerosis	0.000214	0.000546	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—atherosclerosis	0.000205	0.000523	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—atherosclerosis	0.0002	0.000509	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000198	0.000505	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOS3—atherosclerosis	0.000196	0.0005	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK3—atherosclerosis	0.000191	0.000486	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—atherosclerosis	0.000185	0.000472	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000183	0.000466	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000175	0.000447	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—atherosclerosis	0.000174	0.000443	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—atherosclerosis	0.000157	0.000401	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NFKB1—atherosclerosis	0.000156	0.000397	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK8—atherosclerosis	0.000153	0.00039	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000148	0.000377	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—atherosclerosis	0.000141	0.00036	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—atherosclerosis	0.00014	0.000356	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—atherosclerosis	0.000139	0.000355	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000139	0.000353	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—atherosclerosis	0.000134	0.00034	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—atherosclerosis	0.00013	0.00033	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—atherosclerosis	0.000129	0.000328	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	0.00011	0.00028	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—atherosclerosis	0.000108	0.000275	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—atherosclerosis	9.76e-05	0.000249	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—atherosclerosis	9.01e-05	0.00023	CbGpPWpGaD
